TARS Tarsus Pharmaceuticals Inc

$72.92

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/17/2025

About Tarsus Pharmaceuticals Inc

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new therapeutic candidates for ophthalmic conditions. The company is headquartered in Irvine, California.

Website: https://www.tarsusrx.com

Sector
LIFE SCIENCES
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1819790
Address
15440 LAGUNA CANYON ROAD, IRVINE, CA, US
Valuation
Market Cap
$2.05B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
9.13
Performance
EPS
$-3.07
Dividend Yield
—
Profit Margin
-63.20%
ROE
-54.80%
Technicals
50D MA
$48.14
200D MA
$41.33
52W High
$57.28
52W Low
$20.08
Fundamentals
Shares Outstanding
42M
Target Price
$70.75
Beta
0.94

TARS EPS Estimates vs Actual

● Estimated
● Actual

TARS News & Sentiment

Nov 05, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Tarsus to Participate in Upcoming Investor Conference
IRVINE, Calif., Nov. 05, 2025 ( GLOBE NEWSWIRE ) -- Tarsus Pharmaceuticals, Inc. ( NASDAQ: TARS ) , today announced that management plans to participate in a fireside chat at the Guggenheim 2nd Annual Healthcare Innovation Conference in Boston, MA on Tuesday, November 11th, at 11:30 a.m.
Nov 05, 2025 • Benzinga SOMEWHAT-BULLISH
Tarsus to Participate in Upcoming Investor Conference - Tarsus Pharmaceuticals ( NASDAQ:TARS )
IRVINE, Calif., Nov. 05, 2025 ( GLOBE NEWSWIRE ) -- Tarsus Pharmaceuticals, Inc. ( NASDAQ:TARS ) , today announced that management plans to participate in a fireside chat at the Guggenheim 2nd Annual Healthcare Innovation Conference in Boston, MA on Tuesday, November 11th, at 11:30 a.m.
Nov 04, 2025 • Zacks Commentary NEUTRAL
Tarsus Pharmaceuticals, Inc. ( TARS ) Reports Q3 Loss, Beats Revenue Estimates
Tarsus Pharmaceuticals (TARS) delivered earnings and revenue surprises of +14.29% and +2.80%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Oct 27, 2025 • Motley Fool SOMEWHAT-BULLISH
Capricorn Fund Loads Up on Phreesia ( PHR ) With a 484,000 Share Purchase
Capricorn Fund Managers Ltd disclosed a new stake in Phreesia ( NYSE:PHR ) , purchasing 484,500 shares valued at $11.4 million as of September 30, 2025. The transaction, detailed in a Securities and Exchange Commission ( SEC ) filing dated October 17, 2025, marks the fund's initial reportable ...
Oct 09, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Vir Biotechnology ( VIR ) Surges 6.9%: Is This an Indication of Further Gains?
Vir Biotechnology (VIR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Oct 06, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Tarsus Pharmaceuticals ( TARS ) Moves 10.9% Higher: Will This Strength Last?
Tarsus Pharmaceuticals (TARS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Sentiment Snapshot

Average Sentiment Score:

0.297
50 articles with scored sentiment

Overall Sentiment:

Bullish

TARS Reported Earnings

Aug 06, 2025
Jun 30, 2025 (Pre market)
-0.1 Surprise
  • Reported EPS: $-0.48
  • Estimate: $-0.38
  • Whisper: —
  • Surprise %: -26.3%
May 01, 2025
Mar 31, 2025 (Pre market)
-0.01 Surprise
  • Reported EPS: $-0.64
  • Estimate: $-0.63
  • Whisper: —
  • Surprise %: -1.6%
Feb 25, 2025
Dec 31, 2024 (Pre market)
0.22 Surprise
  • Reported EPS: $-0.60
  • Estimate: $-0.82
  • Whisper: —
  • Surprise %: 26.4%
Nov 13, 2024
Sep 30, 2024 (Post market)
0.33 Surprise
  • Reported EPS: $-0.61
  • Estimate: $-0.94
  • Whisper: —
  • Surprise %: 35.1%
Aug 08, 2024
Jun 30, 2024 (Post market)
0.04 Surprise
  • Reported EPS: $-0.88
  • Estimate: $-0.92
  • Whisper: —
  • Surprise %: 4.3%
May 08, 2024
Mar 31, 2024 (Post market)
0.19 Surprise
  • Reported EPS: $-1.01
  • Estimate: $-1.20
  • Whisper: —
  • Surprise %: 15.8%
Feb 27, 2024
Dec 31, 2023 (Pre market)
0.05 Surprise
  • Reported EPS: $-1.31
  • Estimate: $-1.36
  • Whisper: —
  • Surprise %: 3.7%
Nov 09, 2023
Sep 30, 2023 (Post market)
0.09 Surprise
  • Reported EPS: $-1.28
  • Estimate: $-1.37
  • Whisper: —
  • Surprise %: 6.6%
Aug 10, 2023
Jun 30, 2023 (Post market)
-0.09 Surprise
  • Reported EPS: $-1.17
  • Estimate: $-1.08
  • Whisper: —
  • Surprise %: -8.3%

Financials